TY - JOUR
T1 - Surgical Experience Disparity between Male and Female Surgeons in Japan
AU - Kono, Emiko
AU - Isozumi, Urara
AU - Nomura, Sachiyo
AU - Okoshi, Kae
AU - Yamamoto, Hiroyuki
AU - Miyata, Hiroaki
AU - Yasufuku, Itaru
AU - Maeda, Hiromichi
AU - Sakamoto, Junichi
AU - Uchiyama, Kazuhisa
AU - Kakeji, Yoshihiro
AU - Yoshida, Kazuhiro
AU - Kitagawa, Yuko
N1 - Funding Information:
receiving personal fees from Olympus, Medtronic, Karl Storz, and Johnson & Johnson outside the submitted work. Dr Nomura reported receiving grants from JCR Pharmaceuticals and Nobelpharma outside the submitted work. Dr Okoshi reported receiving personal fees from Stryker Japan, CONMED Japan, Johnson & Johnson, Meilleur, AMCO Incorporated, and Taiho Pharmaceutical outside the submitted work. Dr Yamamoto reported receiving grants from the National Clinical Database, Johnson & Johnson, and Nipro Co during the conduct of the study; consultation fees from Mitsubishi Tanabe Pharma Corporation, speaker fees from Chugai Pharmaceutical Co, Ltd and Ono Pharmaceutical Co, Ltd, and payment for a manuscript from Astellas Pharma Inc outside the submitted work. Dr Miyata reported receiving grants from the National Clinical Database and Johnson & Johnson outside the submitted work. Dr Maeda reported receiving personal fees from Merck Biopharma Co, Ltd and Tsumura & Co outside the submitted work. Dr Yoshida reported receiving personal fees from Taiho Pharmaceutical, Chugai Pharmaceutical Co, Ltd, Takeda, Eli Lilly, Daiichi Sankyo, Merck Serono, Johnson & Johnson, Nippon Covidien, Bayer Yakuhin, Olympus, Terumo, Otsuka, Sanofi, Denka, Nippon Kayaku, Merck Sharp & Dohme, Yakult Honsha, Tsumura & Co, Pfizer, Intuitive Surgical, Ono Pharmaceutical Co, Ltd, and Asahi Kasei and grants from Sanofi, Yakult Honsha, Chugai Pharmaceutical Co, Ltd, Takeda, Eli Lilly, Taiho Pharmaceutical, Daiichi Sankyo, Johnson & Johnson, Nippon Covidien, Otsuka, Nippon Kayaku, Tsumura & Co, Eisai, Kyowa Hakko Kirin, Astellas Pharma Inc, Toyama Chemical, KCI Ltd, Abbott, Toray Medical, and Asahi Kasei outside the submitted work. Dr Kitagawa reported receiving grants from Chugai Pharmaceutical Co, Ltd, Taiho Pharmaceutical, Yakult Honsha, Asahi Kasei, Otsuka, Takeda, Ono Pharmaceutical Co, Ltd, Tsumura & Co, Kyouwa Hakkou Kirin, EA Pharma, Medicon Inc, Kaken Pharmaceutical, Eisai, Otsuka, Teijin Pharma Limited, Nihon Pharmaceutical, and Nippon Covidien, and personal fees from Asahi Kasei, AstraZeneca, Ethicon Inc, Ono Pharmaceutical Co, Ltd, Otsuka, Olympus, Nippon Covidien, Shionogi & Co, Taiho Pharmaceutical, Chugai Pharmaceutical Co, Ltd, Bristol Myers Squibb, Merck Sharp & Dohme, Smith & Nephew, Kaken Pharmaceutical, and ASKA Pharmaceutical outside the submitted work. No other disclosures were reported.
Funding Information:
Funding/Support: This study was supported by the project expenses of the Council of Societies Related to the Gastroenterological Database.
Publisher Copyright:
© 2022 American Medical Association. All rights reserved.
PY - 2022/9
Y1 - 2022/9
N2 - Importance: Women are vastly underrepresented in surgical leadership and management in Japan. The lack of equal opportunities for surgical training is speculated to be the main reason for this disparity; however, this hypothesis has not been investigated thus far. Objective: To examine gender disparity in the number of surgical experiences among Japanese surgeons. Design, Setting, and Participants: This retrospective, multicenter cross-sectional study used data from the National Clinical Database, which contains more than 95% of all surgical procedures in Japan. Participants included male and female gastroenterological surgeons who performed appendectomy, cholecystectomy, right hemicolectomy, distal gastrectomy, low anterior resection, and pancreaticoduodenectomy between January 1, 2013, and December 31, 2017. Exposures: Differences in the number of surgical experiences between male and female surgeons. Main Outcomes and Measures: The primary outcomes were the total number of operations and number of operations per surgeon by gender and years of experience. Data were analyzed from March 18 to August 31, 2021. Results: Of 1147068 total operations, 83354 (7.27%) were performed by female surgeons and 1063714 (92.73%) by male surgeons. Among the 6 operative procedures, the percentage of operations performed by female surgeons were the highest for appendectomy (n = 20648 [9.83%]) and cholecystectomy (n = 41271 [7.89%]) and lowest for low anterior resection (n = 4507 [4.57%]) and pancreaticoduodenectomy (n = 1329 [2.64%]). Regarding the number of operations per surgeon, female surgeons had fewer surgical experiences for all 6 types of operations in all years after registration, except for appendectomy and cholecystectomy in the first 2 years after medical registration. The largest gender disparity for each surgical procedure was 3.17 times more procedures for male vs female surgeons for appendectomy (at 15 years after medical registration), 4.93 times for cholecystectomy (at 30-39 years), 3.65 times for right hemicolectomy (at 30-39 years), 3.02 times for distal gastrectomy (at 27-29 years), 6.75 times for low anterior resection (at 27-29 years), and 22.2 times for pancreaticoduodenectomy (at 30-39 years). Conclusions and Relevance: This cross-sectional study found that female surgeons had less surgical experience than male surgeons in Japan, and this gap tended to widen with an increase in years of experience, especially for medium- and high-difficulty operations. Gender disparity in surgical experience needs to be eliminated, so that female surgeons can advance to leadership positions..
AB - Importance: Women are vastly underrepresented in surgical leadership and management in Japan. The lack of equal opportunities for surgical training is speculated to be the main reason for this disparity; however, this hypothesis has not been investigated thus far. Objective: To examine gender disparity in the number of surgical experiences among Japanese surgeons. Design, Setting, and Participants: This retrospective, multicenter cross-sectional study used data from the National Clinical Database, which contains more than 95% of all surgical procedures in Japan. Participants included male and female gastroenterological surgeons who performed appendectomy, cholecystectomy, right hemicolectomy, distal gastrectomy, low anterior resection, and pancreaticoduodenectomy between January 1, 2013, and December 31, 2017. Exposures: Differences in the number of surgical experiences between male and female surgeons. Main Outcomes and Measures: The primary outcomes were the total number of operations and number of operations per surgeon by gender and years of experience. Data were analyzed from March 18 to August 31, 2021. Results: Of 1147068 total operations, 83354 (7.27%) were performed by female surgeons and 1063714 (92.73%) by male surgeons. Among the 6 operative procedures, the percentage of operations performed by female surgeons were the highest for appendectomy (n = 20648 [9.83%]) and cholecystectomy (n = 41271 [7.89%]) and lowest for low anterior resection (n = 4507 [4.57%]) and pancreaticoduodenectomy (n = 1329 [2.64%]). Regarding the number of operations per surgeon, female surgeons had fewer surgical experiences for all 6 types of operations in all years after registration, except for appendectomy and cholecystectomy in the first 2 years after medical registration. The largest gender disparity for each surgical procedure was 3.17 times more procedures for male vs female surgeons for appendectomy (at 15 years after medical registration), 4.93 times for cholecystectomy (at 30-39 years), 3.65 times for right hemicolectomy (at 30-39 years), 3.02 times for distal gastrectomy (at 27-29 years), 6.75 times for low anterior resection (at 27-29 years), and 22.2 times for pancreaticoduodenectomy (at 30-39 years). Conclusions and Relevance: This cross-sectional study found that female surgeons had less surgical experience than male surgeons in Japan, and this gap tended to widen with an increase in years of experience, especially for medium- and high-difficulty operations. Gender disparity in surgical experience needs to be eliminated, so that female surgeons can advance to leadership positions..
UR - http://www.scopus.com/inward/record.url?scp=85135482078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135482078&partnerID=8YFLogxK
U2 - 10.1001/jamasurg.2022.2938
DO - 10.1001/jamasurg.2022.2938
M3 - Article
C2 - 35895067
AN - SCOPUS:85135482078
SN - 2168-6254
VL - 157
SP - E222938
JO - JAMA Surgery
JF - JAMA Surgery
IS - 9
ER -